awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q59126123-34788E7F-6DC5-4494-8D8D-BA902550FC9E
Q59126123-34788E7F-6DC5-4494-8D8D-BA902550FC9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59126123-34788E7F-6DC5-4494-8D8D-BA902550FC9E
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
P2860
Q59126123-34788E7F-6DC5-4494-8D8D-BA902550FC9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59126123-34788E7F-6DC5-4494-8D8D-BA902550FC9E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b629619ba82cdfda7877081b29a47a58d9d7c119
P2860
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inf